Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Non-Myeloablative Stem Cell Transplants

Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases

Abstract

Using a non-myeloablative, immunosuppressive, fludarabine-based conditioning regimen, we performed allogeneic peripheral blood stem cell transplants totally on an outpatient basis in four patients (two with chronic myelogenous leukemia, one with acute myelogenous leukemia and one with thalassemia major). The median granulocyte recovery time to 0.5 × 109/l was 10 days and the lowest absolute neutrophil count was 0.064 × 109/l; only one patient developed thrombocytopenia below 20 × 109/l. No patient required red blood cell transfusions and one was given a single prophylactic platelet transfusion. All patients are alive at 210–390 (median 285) days and have definite evidence of chimerism; one developed biopsy-proven GVHD on day 50, with a limited cutaneous rash. The procedure is less costly than its counterpart using myeloablative conditioning regimens and may represent another approach in the management of patients requiring an allogeneic stem cell transplant. Bone Marrow Transplantation (2000) 25, 131–133.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Negrin R, Storb R, Forman S . Bone marrow transplantation in malignant disease. In: McArthur JR, Schechter GP, Schrier SL (eds) Hematology 1998 The American Society of Hematology Education Program Book: Washington 1998 pp 342–370

    Google Scholar 

  2. Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeoablative therapy Blood 1997 89: 4331–4336

    Google Scholar 

  3. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematological diseases Blood 1998 91: 756–763

    CAS  PubMed  Google Scholar 

  4. Khouri IF, Keating M, Korbling M et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies J Clin Oncol 1998 16: 2817–2824

    Article  CAS  PubMed  Google Scholar 

  5. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B et al. Filgrastim-mobilized peripheral-blood stem cells can be stored at 4 degrees and used in autografts to rescue high-dose chemotherapy Am J Hematol 1995 48: 100–103

    Article  PubMed  Google Scholar 

  6. Gómez-Almaguer D, Ruiz-Argüelles GJ, Ruiz-Argüelles A, Piñeiro LA . Dos casos de trasplante heterólogo con sangre periférica Rev Invest Clin Méx 1997 49: 41–45

    Google Scholar 

  7. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B et al. Non-cryopreserved peripheral blood stem cells autotransplants for hematological malignancies can be performed entirely on an outpatient basis Am J Hematol 1998 58: 161–164

    Article  PubMed  Google Scholar 

  8. Kessinger A, Armitage JO, Landmark JD et al. Autologous peripheral hematopoietic stem cell transplantation restores hemopoietic function following marrow ablative therapy Blood 1998 71: 723–727

    Google Scholar 

  9. Ruiz-Argüelles A . Flow cytometry in the clinical laboratory. Principles, applications and problems Ann Biol Clin 1992 50: 735–743

    Google Scholar 

  10. Ruiz-Argüelles A, Orfao A . Caracterización y evaluación de células totipotenciales en sangre periférica y médula ósea. In: Ruiz-Argüelles GJ, San-Miguel JF (eds) Actualización en Leucemias Editorial Médica Panamericana: México City 1996 pp 79–82

    Google Scholar 

  11. Pinkel D, Straume T, Gray JW . Citogenetic analysis using quantitative, high sensitivity fluorescence hybridization Proc Natl Acad Sci USA 1996 83: 2934–2938

    Article  Google Scholar 

  12. Armitage JO . Bone marrow transplantation New Engl J Med 1994 330: 827–838

    Article  CAS  PubMed  Google Scholar 

  13. Thomas ED . Hematopoietic stem cell transplantation Sci Am 1995 272: 38–47

    Google Scholar 

  14. Ruiz-Argüelles GJ, Bruno GV . Trasplante de células toti-potenciales hematopoyéticas. In: Castellanos-Coutiño J (ed) Temas de Medicina Interna: Transplante de órganos. Asociación de Medicina Interna de México McGraw Hill/Interamericana: México City 1998 pp 85–99

    Google Scholar 

  15. Vesole DH, Tricot G, Jagannath S, et al . Autotransplants in multiple myeloma: what have we learned? Blood 1996 88: 838–847

    CAS  PubMed  Google Scholar 

  16. Ruiz-Argüelles GJ, Apreza-Molina MG, Alemán-Hoey DD et al. Outpatient supportive therapy after induction to remission therapy in adult acute myelogenous leukaemia (AML) is feasible: a multicentre study Eur J Haematol 1995 54: 18–20

    PubMed  Google Scholar 

  17. Ruiz-Argüelles GJ, Lobato-Mendizábal E, Delgado-Lamas JL, Gómez-Almaguer D . All trans-retinoic acid decreases early mortality in patients with promyelocytic leukemia and can be given entirely on an outpatient basis Am J Hematol 1999 62: 139–143

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gómez-Almaguer, D., Ruiz-Argüelles, G., Ruiz-Argüelles, A. et al. Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases. Bone Marrow Transplant 25, 131–133 (2000). https://doi.org/10.1038/sj.bmt.1702100

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702100

Keywords

This article is cited by

Search

Quick links